740
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Radiotherapy

Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma

ORCID Icon, , &
Pages 1412-1416 | Received 05 May 2022, Accepted 05 Oct 2022, Published online: 20 Oct 2022

References

  • Scotto J, Fraumeni JF Jr., Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst. 1976;56(3):489–491.
  • Shields CL, Shields JA, Milite J, et al. Uveal melanoma in teenagers and children. A report of 40 cases. Ophthalmology. 1991;98(11):1662–1666.
  • Damato B. The role of eyewall resection in uveal melanoma management. Int Ophthalmol Clin. 2006;46(1):81–93.
  • Damato B. Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther. 2006;6(4):493–506.
  • Daftari IK, Petti PL, Shrieve DC, et al. Newer radiation modalities for choroidal tumors. Int Ophthalmol Clin. 2006;46(1):69–79.
  • Damato B. Developments in the management of uveal melanoma. Clin Exp Ophthalmol. 2004;32(6):639–647.
  • Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124(12):1684–1693.
  • Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report No. 18. Arch Ophthalmol. 2001;119(7):969–982.
  • Zorlu F, Selek U, Kiratli H. Initial results of fractionated CyberKnife radiosurgery for uveal melanoma. J Neurooncol. 2009;94(1):111–117.
  • Gambrelle J, Grange JD, Devouassoux Shisheboran M, et al. Survival after primary enucleation for choroidal melanoma: changes induced by the introduction of conservative therapies. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):657–663.
  • Gragoudas ES. Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci. 2006;47(11):4666–4673.
  • Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65(3):780–787.
  • Bechrakis NE, Bornfeld N, Zoller I, et al. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas. Ophthalmology. 2002;109(10):1855–1861.
  • Bergman L, Nilsson B, Lundell G, et al. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology. 2005;112(5):834–840.
  • Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of ıodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report No. 19. Ophthalmology. 2020;127(4S):S148–S157.
  • Gragoudas E, Li W, Goitein M, et al. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002;120(12):1665–1671.
  • Williams DF, Mieler WF, Jaffe GJ, et al. Magnetic resonance imaging of juxtapapillary plaques in cadaver eyes. Br J Ophthalmol. 1990;74(1):43–46.
  • Harbour JW, Murray TG, Byrne SF, et al. Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina. 1996;16(2):129–134.
  • Fili M, Astrahan M, Stalhammar G. Long-term outcomes after enucleation or plaque brachytherapy of choroidal melanomas touching the optic disc. Brachytherapy. 2021;20(6):1245–1256.
  • Zehetmayer M. Stereotactic photon beam irradiation of uveal melanoma. Dev Ophthalmol. 2012;49:58–65.
  • Choi SY, Kim MS, Yoo SY, et al. Feasibility of image-guided robotic radiotherapy using three fractions for uveal melanoma. Tumori. 2009;95(6):720–725.
  • Muacevic A, Nentwich M, Wowra B, et al. Development of a streamlined, non-invasive robotic radiosurgery method for treatment of uveal melanoma. Technol Cancer Res Treat. 2008;7(5):369–373.
  • Fakiris AJ, Lo SS, Henderson MA, et al. Gamma-knife-based stereotactic radiosurgery for uveal melanoma. Stereotact Funct Neurosurg. 2007;85(2–3):106–112.
  • Weber DC, Bogner J, Verwey J, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: a comparative study. Int J Radiat Oncol Biol Phys. 2005;63(2):373–384.
  • Dunavoelgyi R, Dieckmann K, Gleiss A, et al. Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys. 2012;83(1):121–128.
  • Krema H, Somani S, Sahgal A, et al. Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up. Br J Ophthalmol. 2009;93(9):1172–1176.
  • Muller K, Naus N, Nowak PJ, et al. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results. Radiother Oncol. 2012;102(2):219–224.
  • Somani S, Sahgal A, Krema H, et al. Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: 2-year follow-up. Can J Ophthalmol. 2009;44(1):61–65.
  • Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998;125(1):81–89.
  • Eibenberger K, Dunavoelgyi R, Gleiss A, et al. Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience. Acta Oncol. 2021;60(2):207–214.
  • De Potter P, Shields CL, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol. 1996;114(11):1357–1365.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.